N. Woodford

2.6k total citations · 1 hit paper
21 papers, 2.0k citations indexed

About

N. Woodford is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, N. Woodford has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Medicine, 11 papers in Endocrinology and 6 papers in Epidemiology. Recurrent topics in N. Woodford's work include Antibiotic Resistance in Bacteria (16 papers), Enterobacteriaceae and Cronobacter Research (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (5 papers). N. Woodford is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Enterobacteriaceae and Cronobacter Research (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (5 papers). N. Woodford collaborates with scholars based in United Kingdom, France and Poland. N. Woodford's co-authors include D. M. Livermore, David M. Livermore, Juan A. Ayala, Gian María Rossolini, Patrice Nordmann, Rafael Cantón, Guillaume Arlet, Teresa M. Coque, Laurent Poirel and Marek Gniadkowski and has published in prestigious journals such as The Lancet, International Journal of Food Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

N. Woodford

21 papers receiving 1.9k citations

Hit Papers

CTX-M: changing the face ... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Woodford United Kingdom 17 1.6k 712 469 462 353 21 2.0k
Inna Chmelnitsky Israel 25 1.6k 1.0× 703 1.0× 357 0.8× 369 0.8× 340 1.0× 38 1.9k
Alejandra Corso Argentina 29 1.4k 0.9× 669 0.9× 374 0.8× 843 1.8× 529 1.5× 119 2.5k
José Campos Spain 29 1.6k 1.0× 739 1.0× 346 0.7× 947 2.0× 229 0.6× 58 2.5k
Annarita Mazzariol Italy 22 1.4k 0.9× 598 0.8× 278 0.6× 529 1.1× 396 1.1× 67 2.0k
Christine Lascols France 25 1.2k 0.8× 544 0.8× 249 0.5× 454 1.0× 271 0.8× 44 2.1k
Martin Kaase Germany 28 1.5k 1.0× 710 1.0× 337 0.7× 616 1.3× 450 1.3× 88 2.3k
Véronique Leflon‐Guibout France 27 2.0k 1.3× 1.2k 1.7× 428 0.9× 678 1.5× 330 0.9× 59 2.7k
Aggeliki Poulou Greece 25 1.6k 1.0× 741 1.0× 389 0.8× 308 0.7× 147 0.4× 36 1.8k
Ellen Smith Moland United States 29 2.3k 1.5× 989 1.4× 622 1.3× 523 1.1× 238 0.7× 52 2.6k
José María Casellas Argentina 17 2.1k 1.4× 714 1.0× 376 0.8× 752 1.6× 384 1.1× 36 2.7k

Countries citing papers authored by N. Woodford

Since Specialization
Citations

This map shows the geographic impact of N. Woodford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Woodford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Woodford more than expected).

Fields of papers citing papers by N. Woodford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Woodford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Woodford. The network helps show where N. Woodford may publish in the future.

Co-authorship network of co-authors of N. Woodford

This figure shows the co-authorship network connecting the top 25 collaborators of N. Woodford. A scholar is included among the top collaborators of N. Woodford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Woodford. N. Woodford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campbell, Duncan J., et al.. (2024). Association of Coronary Microvascular Rarefaction and Myocardial Fibrosis With Coronary Artery Disease. Journal of the American Heart Association. 13(21). e037332–e037332. 4 indexed citations
2.
Mushtaq, Shazad, et al.. (2024). Frequencies and mechanisms of mutational resistance to ceftibuten/avibactam in Enterobacterales. Journal of Antimicrobial Chemotherapy. 80(3). 645–656. 2 indexed citations
3.
Horner, Carolyne, Shazad Mushtaq, David M. Livermore, et al.. (2020). Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data. Journal of Antimicrobial Chemotherapy. 75(11). 3239–3243. 15 indexed citations
4.
Hopkins, Katie L., Danièle Meunier, Claire Perry, et al.. (2016). Carbapenemase-producing Enterobacteriaceae in hospital wastewater: a reservoir that may be unrelated to clinical isolates. Journal of Hospital Infection. 93(2). 145–151. 46 indexed citations
5.
Randall, Luke, Nicola Elviss, Fabrizio Lemma, et al.. (2016). Evaluation of meat, fruit and vegetables from retail stores in five United Kingdom regions as sources of extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Escherichia coli. International Journal of Food Microbiology. 241. 283–290. 81 indexed citations
6.
Hopkins, Katie L., Jane F. Turton, Michel Doumith, et al.. (2014). NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. Journal of Antimicrobial Chemotherapy. 69(7). 1777–1784. 55 indexed citations
7.
Livermore, David M., Shazad Mushtaq, M. Warner, & N. Woodford. (2013). Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 69(4). 1050–1056. 24 indexed citations
8.
Livermore, D. M., Russell Hope, Rosy Reynolds, et al.. (2013). Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?. Journal of Antimicrobial Chemotherapy. 68(11). 2667–2674. 78 indexed citations
9.
Livermore, David M., J. M. Andrews, Peter M. Hawkey, et al.. (2012). Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. Journal of Antimicrobial Chemotherapy. 67(7). 1569–1577. 105 indexed citations
10.
Morris, Dearbháile, Fiona Boyle, Carol Morris, et al.. (2012). Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. Journal of Antimicrobial Chemotherapy. 67(10). 2367–2372. 26 indexed citations
11.
Dhanji, H., Michel Doumith, Paul J. Rooney, et al.. (2010). Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum  -lactamases in nursing homes in Belfast, UK. Journal of Antimicrobial Chemotherapy. 66(2). 297–303. 51 indexed citations
12.
Dhanji, H., Niamh Murphy, Michel Doumith, et al.. (2010). Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. Journal of Antimicrobial Chemotherapy. 65(12). 2534–2537. 74 indexed citations
13.
Hill, Robert L., Angela Kearns, James D. Nash, et al.. (2010). Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. Journal of Antimicrobial Chemotherapy. 65(3). 442–445. 52 indexed citations
14.
Rooney, Paul J., Anne Loughrey, Bobby P. Smyth, et al.. (2009). Nursing homes as a reservoir of extended-spectrum  -lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy. 64(3). 635–641. 162 indexed citations
15.
Livermore, D. M., Shazad Mushtaq, M. Warner, & N. Woodford. (2009). Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci. Journal of Antimicrobial Chemotherapy. 63(4). 713–715. 72 indexed citations
16.
Alfa, Michelle J., Fernando Baquero, Jérôme Étienne, et al.. (2008). Healthcare-associated infections: think globally, act locally. Clinical Microbiology and Infection. 14(10). 895–907. 41 indexed citations
17.
Lau, S. H., Mary E. Kaufmann, David M. Livermore, et al.. (2008). UK epidemic Escherichia coli strains A-E, with CTX-M-15  -lactamase, all belong to the international O25:H4-ST131 clone. Journal of Antimicrobial Chemotherapy. 62(6). 1241–1244. 144 indexed citations
18.
Woodford, N., Jian Zhang, M. Warner, et al.. (2008). Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. Journal of Antimicrobial Chemotherapy. 62(6). 1261–1264. 116 indexed citations
19.
Livermore, D. M., Rafael Cantón, Marek Gniadkowski, et al.. (2006). CTX-M: changing the face of ESBLs in Europe. Journal of Antimicrobial Chemotherapy. 59(2). 165–174. 739 indexed citations breakdown →
20.
Uttley, A.H.C., N. Woodford, Alan P. Johnson, et al.. (1993). Vancomycin-resistant enterococci. The Lancet. 342(8871). 615–617. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026